US Patent 10526630 Genetically modified mice that produce hybrid antibodies
Patent 10526630 was granted and assigned to Regeneron Pharmaceuticals on January, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 4, 2013
Date of Patent
January 7, 2020
Patent Applicant
Patent Application Number
14046291
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10526630 Genetically modified mice that produce hybrid antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
